Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-037 manufacturers

Filters

None products found

pp-037

Injection, pre-filled pen

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
Comments
Indication: Primary: Acromegaly (patients controlled on somatostatin receptor ligands), submitted for registration . Additional: Gastroenteropancreatic neuroendocrine tumors (GEP-NET)- Phase III, Polycystic Liver Disease (PLD) in development- Phase II. A long-acting, subcutaneous depot formulation of the somatostatin analogue Octreotide, developed using proprietary patented technology for sustained release and improved bioavailability. Designed for once-monthly self-administration with a pre-filled autoinjector pen, enhancing convenience versus intramuscular or more frequent injection regimens. Differentiation: Better bioavailability and no lag phase after injection; supports improved patient convenience and self-administration.
Manufacturer #38501

This Swedish biopharmaceutical organization develops and commercializes long-acting treatments for severe and chronic diseases. It specializes in advanced drug-delivery systems designed to improve therapeutic outcomes and patient adherence. Its portfolio includes marketed products and a research pipeline targeting areas such as opioid dependence, endocrine disorders, and oncology.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.